K2 Principal Fund, L.P. Bausch Health Companies Inc. Call Options Transaction History

K2 Principal Fund, L.P.

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$7.06 - $23.63 $1.26 Million - $4.22 Million	-178,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $159,840 - $205,646	7,400 Added 4.33%	178,400 $4.08 Million
Q4 2021 Feb 11, 2022	SELL	$23.0 - $29.01 $6.3 Million - $7.94 Million	-273,800 Reduced 61.56%	171,000 $4.72 Million
Q3 2021 Nov 12, 2021	BUY	$25.04 - $30.06 $9.89 Million - $11.9 Million	394,800 Added 789.6%	444,800 $12.4 Million
Q2 2021 Aug 13, 2021	BUY	$27.43 - $32.7 $1.37 Million - $1.64 Million	50,000 New	50,000 $1.47 Million
Q1 2021 May 14, 2021	SELL	$21.37 - $34.38 $5.24 Million - $8.42 Million	-245,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $2.99 Million - $4.12 Million	195,000 Added 390.0%	245,000 $5.1 Million
Q3 2020 Nov 13, 2020	SELL	$14.88 - $20.13 $3.24 Million - $4.38 Million	-217,700 Reduced 81.32%	50,000 $777,000
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $2.76 Million - $4.26 Million	207,700 Added 346.17%	267,700 $4.9 Million
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $778,800 - $1.82 Million	60,000 New	60,000 $930,000

252

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.63B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.